Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |